Global Transformation Infectious Disease Mitigation SummitUniversity of Texas – DallasVenture Development CenterDecember 3, 2014

2Introduction

Mark Stratton, Vice President M&S 25 years of disruptive technology development

Global systems and services implementations

Pathogen mobility analysis and solution modeling

Brian Searcy, Vice President Operations 30 years of advanced technology deployment

Standup and mature global support management

Pathogen inhibitor best practices and education

For WAACCI and E-Mist Innovations use only.

3

E-Mist Innovations DeliversSurface Transferrable Pathogen Management

Thirty year veterans in surface inhibitor application technology development

Mission: To consistently interrupt the mobility of infectious pathogens

Vision: Through continuous application technology innovation and superior manufacturing, empower everyone to achieve healthy surface touch point environments simply and cost effectively

For WAACCI and E-Mist Innovations use only.

4

Ingress Pathogens Misguided Focus

Pathogen Mobility

Airlines & Transport

Hospital & Medical

Education & Athletics

Food Processing & Agriculture

Office -Retail

Restaurants

Hospitality & Lodging

Government & Military

Residential & Long Term

Care

• Arriving pathogens uncontrollable

• Resident pathogens become custody of surface environment owner

• Interruption of mobility a more practical and achievable goal

For WAACCI and E-Mist Innovations use only.

5

Egress Pathogen Strategy Is Working Limited

Pathogen Mobility Overlap

Airlines & Transport

Hospital & Medical

Education & Athletics

Food Processing & Agriculture

Office -Retail

Restaurants

Hospitality & Lodging

Government & Military

Residential & Long Term

Care

• Allowing egress irresponsible

• Proper surface disinfection interrupting continual chain of mobility

• Collaboration of surface owners under way

For WAACCI and E-Mist Innovations use only.

Ingress

Egress

6The Gap Between Effort And Results

The expectation is that cleaning while disinfecting is delivering healthy touch point surfaces

Spraying-and-wiping, in particular, cancels disinfectant effectiveness - and touching surfaces spreads pathogens every time

New options are closing the gap between healthy surface expectations and current effort shortfalls

For WAACCI and E-Mist Innovations use only.

7Proper Surface Disinfection

Establish disinfection steps separate from cleaning

Disinfection needs exceed cleaning capabilities

Align strategy with actual pathogen behaviors

Fully leverage disinfectant delivery technology advancements

Frequency

Agent

Coverage

Touchless

Safety

F

A

C

T

S

For WAACCI and E-Mist Innovations use only.

8

E-Mister Surface Disinfection Management System

Basic skill-level operation

Mobile, agile, flexible

Two component system

Rolling battery pack & tank

Quick connect E-Misting wand

Simple tank flushing

Simple battery recharge

Lifetime replacement and support

For WAACCI and E-Mist Innovations use only.

9

E-Mister Details

Patented electrostatic droplet delivery

Liquid-efficient droplet adhesion

Non-inhalation droplet sizing and shaping

Delivers any water soluble agent

Disinfection and odor management

Average 6,000 touch point treatments per tank

Single battery operation – spare provided

Quiet, light weight wand

Hardened case with easy fill cap

USA manufacturing within ISO 9001:2008, ISO 13485:2003, FDA Registration 1648571

For WAACCI and E-Mist Innovations use only.

10

E-MisterAircraft Cabin Example

Volume of high priority touch points demonstrates the need for new application technology in order to be successful

Boeing 737-800 150 seats

14 average seat surface touch points

2,100 average total seat surface high use surface touch points

Unhealthy touch point disinfection results Less than 10 minutes

Average Single Seat Touch Points Including Safety Belts: 14

For WAACCI and E-Mist Innovations use only.

11

Simple And Complex In-Service Environments

Preventative in-service: Hospitals

Nursing homes

School districts

Entertainment venues

Outbreak in-service: Ebola

Influenza

Norovirus

Staphylococcus

Escherichia coli

Clostridium difficile

For WAACCI and E-Mist Innovations use only.

12

FACTS™

Proper Surface Management And Disinfection Comparison

FACTS™ Proper Surface Management And Disinfection Protocol

Ability To Meet Goals With Current Methods

Ability To Meet Goals With Touch Point Healthy E-Mister

Frequency

Agent

Coverage

Touchless

Safety

For WAACCI and E-Mist Innovations use only.

13

E-Mist Innovations

Thank You!

844.56E-MIST

TouchPointHealthy.com

Touch Point Healthy Surface Management Systems™

ISO 9001:2008

ISO 13485:2003

FDA Reg: 1648571

Patent US8746597

© 2014 All Rights Reserved

For WAACCI and E-Mist Innovations use only.